Redmile Group’s 1Life Healthcare ONEM Stock Holding History

Redmile Group’s Portfolio ONEM Stock Details ONEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,326,625	Closed	-$38.9M	–	80
2022 Q4	$38.9M	Sell	2,326,625 -1,761,000	-43%	-$29.7M	1.59%	23
2022 Q3	$70.1M	Sell	4,087,625 -434,200	-10%	-$6.82M	2.72%	10
2022 Q2	$35.5M	Buy	4,521,825 +1,116,990	+33%	+$9.6M	1.35%	25
2022 Q1	$37.7M	Buy	+3,404,835	New	+$38.1M	1.18%	26
2021 Q4	–	Sell	-600,432	Closed	-$12.2M	–	80
2021 Q3	$12.2M	Sell	600,432 -1,066,531	-64%	-$27.4M	0.21%	61
2021 Q2	$55.1M	Buy	1,666,963 +1,104,649	+196%	+$41.7M	0.82%	37
2021 Q1	$22M	Sell	562,314 -2,746,880	-83%	-$129M	0.31%	66
2020 Q4	$144M	Sell	3,309,194 -35,500	-1%	-$1.21M	1.75%	17
2020 Q3	$94.9M	Buy	3,344,694 +334,010	+11%	+$10.5M	1.74%	13
2020 Q2	$109M	Sell	3,010,684 -112,700	-4%	-$3.17M	2.02%	14
2020 Q1	$56.7M	Buy	+3,123,384	New	+$68.5M	1.59%	21

Redmile Group's ONEM Position: Q1 2023 in Review

Redmile Group sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 2,326,625 shares — an estimated $38.9M sold.

Redmile Group first reported a position in ONEM in Q1 2020 and held it in 11 quarters. The position peaked at $144M in Q4 2020. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

Redmile Group reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
Redmile Group sold 2,326,625 1Life Healthcare shares in Q1 2023, an estimated $38.9M.
Redmile Group first reported a position in 1Life Healthcare in Q1 2020 and held it in 11 quarters.
Redmile Group's 1Life Healthcare position peaked at $144M in Q4 2020.
0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on Redmile Group's 13F filing for Q1 2023, filed 15 May 2023.